Literature DB >> 30019416

Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome.

Ho Yan Queenie Wong1,2, Hang Wun Raymond Li1, Karen Siu Ling Lam3, Sidney Tam3,4, Chi Chung Shek5, Chi Yan Vivian Lee1, William Shu Biu Yeung1, Pak Chung Ho1, Ernest Hung Yu Ng1.   

Abstract

OBJECTIVE: This study aimed at investigating the association of serum vitamin D (25(OH)D) and anti-Mullerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS) as well as non-PCOS healthy ovulatory women and the possible confounding effects of adiposity and androgen.
METHOD: This was a cross-sectional study conducted on serum samples collected from 451 women diagnosed with PCOS as well as 244 age-matched healthy ovulatory women in a tertiary gynaecology out-patient clinic and a family planning clinic.
RESULTS: Serum 25(OH)D level was significantly higher in women recruited during summer and autumn than those recruited in winter and spring. Both serum 25(OH)D and AMH levels peaked during summer in women with PCOS. In ovulatory women, only serum 25(OH)D but not AMH level showed such seasonal variation. Serum 25(OH)D level in women with PCOS significantly correlated positively with AMH, AMH/antral follicle count (AFC) ratio, serum total testosterone, sex-hormone-binding globulin and quantitative insulin-sensitivity check index and inversely with body mass index (BMI), insulin, triglycerides and homeostatic model assessment of insulin resistance. After controlling for BMI, 25(OH)D level remained significantly correlated positively with serum AMH, AMH/AFC and total testosterone, and inversely with triglycerides. 25(OH)D level was an independent predictor of serum AMH level after controlling for age, BMI and free androgen index in women with PCOS.
CONCLUSION: Serum 25(OH)D level is an independent factor significantly associated with AMH level in women with PCOS but not in ovulatory women.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  25-hydroxyvitamin D; adiposity; androgen; anti-Mullerian hormone; polycystic ovary syndrome; vitamin D

Mesh:

Substances:

Year:  2018        PMID: 30019416     DOI: 10.1111/cen.13816

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  The effect of medication on serum anti-müllerian hormone (AMH) levels in women of reproductive age: a meta-analysis.

Authors:  Wei-Wei Yin; Chang-Chang Huang; Yi-Ru Chen; Dan-Qing Yu; Min Jin; Chun Feng
Journal:  BMC Endocr Disord       Date:  2022-06-14       Impact factor: 3.263

2.  The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome.

Authors:  Jakub Mesinovic; Helena J Teede; Soulmaz Shorakae; Gavin W Lambert; Elisabeth A Lambert; Negar Naderpoor; Barbora de Courten
Journal:  Nutrients       Date:  2020-04-26       Impact factor: 5.717

3.  Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI.

Authors:  Nina Rogenhofer; Udo Jeschke; Viktoria von Schönfeldt; Sven Mahner; Christian J Thaler
Journal:  Arch Gynecol Obstet       Date:  2022-02-27       Impact factor: 2.493

Review 4.  The Association between Vitamin D and Anti-Müllerian Hormone: A Systematic Review and Meta-Analysis.

Authors:  Irene Moridi; Alice Chen; Oded Tal; Reshef Tal
Journal:  Nutrients       Date:  2020-05-28       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.